What Happened?
Cambridge, MA-based Sensorion Appointed Bernd Schmidt as Chief Technical Officer
Date of management change: December 12, 2023
Cambridge, MA-based Sensorion Appointed Bernd Schmidt as Chief Technical Officer
Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness including OTOF-GT, targeting deafness caused by a mutation of the gene encoding for otoferlin, and hearing loss related to mutation in GJB2 gene to potentially address important hearing loss segments in adults and children (GJB2-GT).
Bernd Schmidt is Chief Technical Officer at Sensorion. Previously, Bernd held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: O'Neil Michael, Barron Jonathan, Giresi Matthew, De Freitas Jared, Bryant LaShauna, Padwad Shri, O`Donnell Stephen, Segura Edwin, Schweitzer Laura, Reynolds Sharon, Lopez-Welsch Lio
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.